Candriam SCA’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-467,026
| Closed | -$6.89M | – | 698 |
|
|
2024
Q3 | $6.89M | Sell |
467,026
-20,000
| -4% | -$313K | 0.04% | 312 |
|
|
2024
Q2 | $6.75M | Buy |
487,026
+112,009
| +30% | +$1.59M | 0.04% | 298 |
|
|
2024
Q1 | $5.9M | Buy |
375,017
+170,010
| +83% | +$2.62M | 0.04% | 318 |
|
|
2023
Q4 | $3.32M | Buy |
+205,007
| New | +$3.35M | 0.02% | 398 |
|
|
2023
Q2 | – | Sell |
-25,851
| Closed | -$414K | – | 818 |
|
|
2023
Q1 | $414K | Sell |
25,851
-51,028
| -66% | -$727K | ﹤0.01% | 815 |
|
|
2022
Q4 | $710K | Sell |
76,879
-21,437
| -22% | -$200K | ﹤0.01% | 762 |
|
|
2022
Q3 | $847K | Buy |
+98,316
| New | +$976K | 0.01% | 745 |
|
|
2022
Q1 | – | Sell |
-268,194
| Closed | -$9.15M | – | 834 |
|
|
2021
Q4 | $9.15M | Buy |
268,194
+8,074
| +3% | +$316K | 0.06% | 273 |
|
|
2021
Q3 | $12.5M | Buy |
260,120
+72,788
| +39% | +$3.37M | 0.09% | 237 |
|
|
2021
Q2 | $8.46M | Sell |
187,332
-109,187
| -37% | -$4.84M | 0.06% | 310 |
|
|
2021
Q1 | $15.3M | Sell |
296,519
-9
| -0% | -$469 | 0.13% | 180 |
|
|
2020
Q4 | $16M | Buy |
296,528
+261,545
| +748% | +$11.8M | 0.13% | 182 |
|
|
2020
Q3 | $1.29M | Sell |
34,983
-527,115
| -94% | -$19.6M | 0.01% | 573 |
|
|
2020
Q2 | $17.4M | Buy |
562,098
+95,433
| +20% | +$2.64M | 0.18% | 137 |
|
|
2020
Q1 | $13.3M | Buy |
466,665
+81
| +0% | +$2.43K | 0.15% | 162 |
|
|
2019
Q4 | $13.6M | Buy |
466,584
+206,383
| +79% | +$4.91M | 0.15% | 162 |
|
|
2019
Q3 | $4.97M | Buy |
260,201
+84,000
| +48% | +$1.97M | 0.07% | 320 |
|
|
2019
Q2 | $3.85M | Buy |
176,201
+43,000
| +32% | +$944K | 0.05% | 388 |
|
|
2019
Q1 | $2.73M | Buy |
+133,201
| New | +$2.31M | 0.03% | 434 |
|
Other funds holding NEO
GF
